Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos

Businesswire04:05

Eversense CGM System Receives ICGM Designation by the US FDA

The first fully implantable continuous glucose monitors can now be integrated with insulin pumps as part of an automated insulin delivery system Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company

BusinesswireApr 30 19:00

Senseonics Board Shift: Schumm Out, Hansen In Until 2025

TipRanksMar 26 04:23

Even Though Sensirion Holding (VTX:SENS) Has Lost CHF67m Market Cap in Last 7 Days, Shareholders Are Still up 48% Over 5 Years

While Sensirion Holding AG (VTX:SENS) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 23% in the last quarter.

Yahoo FinanceMar 13 17:46

SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS

Eligible individuals in the U.S. will pay $99 out of pocket for each 6-month CGM system, offering each year of continuous glucose monitoring for just $200* PARSIPPANY, N.J., March 12, 2024 /PRNewswir

PR NewswireMar 12 19:00

HC Wainwright & Co. Reiterates Buy on Senseonics Holdings, Maintains $2 Price Target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Senseonics Holdings with a Buy and maintains $2 price target.

Analyst UpgradesMar 11 19:20